I wasn't referring to the phase 3 results, but the completion of enrollment of the phase 3 trial. Shortly after that is announced, many subscription based biotech trading sites will recommed their subscribers to start buying for the runup to the phase 3 results.
I do think DB will initiate coverage not long after enrollment has been completed.